Mycoplasma pneumoniae肺炎和Streptococcus pneumoniae肺炎之间的临床差异:一个病例控制研究
Jinping Ruan1,2, Zhou Fu2, Linyan Ying2,3,4
1Department of Pediatrics, Chongqing Red Cross Hospital (People's Hospital of Jiangbei District), Chongqing, China.
Frontiers in pediatrics
|August 5, 2024
概括
患有Mycoplasma pneumoniae肺炎 (MPP) 的儿童通常年龄较大,有发烧和干咳. 细菌肺炎肺炎 (SPP) 在较小的儿童中更为常见,并与喘息和易怒相关.
科学领域:
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
- 呼吸系统医学 呼吸系统医学
背景情况:
- 菌性肺炎肺炎 (MPP) 和菌性肺炎肺炎 (SPP) 是儿科呼吸道感染的常见原因.
- 区分MPP和SPP对于适当的治疗和管理至关重要.
研究的目的:
- 调查和比较诊断为MPP和SPP的儿童之间的明显的临床特征和实验室发现.
- 确定用于早期区分这两种常见的儿科肺炎类型的关键指标.
主要方法:
- 一项回顾性研究分析了五年 (2015年1月 - 2020年1月) 期间被诊断为MPP或SPP的入院儿童的数据.
- 临床特征的比较,包括年龄,症状 (发烧,咳,多呼吸,腹,喘息,蓝色,易怒) 和入院前的抗生素使用.
- 分析实验室检测结果,如白细胞计数,中性粒细胞和淋巴细胞百分比,ALT,AST,LDH和前素 (PCT) 水平.
主要成果:
- 总共有506名MPP患者与311名SPP患者进行了比较.
- 患有MPP的患者年龄较大 (中位数为60个月,而SPP为24个月),发烧,干咳,多呼吸和腹的频率更高 (p <0.01).
- SPP患者更有可能出现喘息,色和易怒 (p < 0.01). 在白细胞计数,中性粒细胞/淋巴细胞百分比,ALT,AST,LDH和PCT水平 (p <0.01) 中观察到显著差异.
- 年龄>48.5个月被确定为MPP的独立预测因素,比LDH水平更高的准确性.
结论:
- 虽然MPP和SPP都有共同的症状,如发烧和咳,但不同的临床和实验室特征有助于区分.
- 年龄,干咳,多呼吸,LDH水平和PCT水平的存在是区分MPP和SPP在儿童中的重要预测因素.
- 48.5个月的年龄值可以帮助早期识别和评估MPP.
更多相关视频
06:04Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
2.3K
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
2.4K
相关概念视频
01:30Pneumonia I: Introduction
216
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
216
01:30Pneumonia III: Complications and Assessment
193
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
193
01:29Pneumonia II: Pathophysiology
238
The pathophysiology of pneumonia involves the following steps:
238
01:28Pneumonia IV: Management
314
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
314